CLAIM #20676 · DHR (DHR) · 2023Q2 earnings call · Jul 25, 2023 · due Dec 31, 2023
“So we think really the second half ends up being flat for Life Science instrumentation, putting the full year at low single digits as the normalization process, if you will, from what has been over several years now, very elevated growth rate continues.”
Rainer Blair · CEO
PENDING
graded after results covering Dec 31, 2023 are reported
Verify independently
SEC filings for DHR ↗ · Claim quote is verbatim from the 2023Q2 earnings call.